MYH10 and nasopharyngeal carcinoma: A tumor suppressor, miR-200a, has been extensively studied, and it has been revealed that its upregulation has been associated with a reduced risk of metastasis in OSCC, while downregulation leads to a significant increase in risk through targeting MYH10 to regulate the migration and invasion of nasopharyngeal carcinoma (NPC) cells [172,173].